Influence of immunosuppression on the prevalence of cancer after kidney transplantation

Transplantation Proceedings

Volumn 35, Issue 5, 2003, Pages 1714-1716

  Marcen R ^b   Pascual, J ^c   Tato, A M ^c   Teruel, J L ^c   Villafruela, J J ^c   Fernandez M ^c   Tenorio, M ^c   Burgos, F J ^a   Ortuno J ^c  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; PREDNISOLONE; TACROLIMUS;

ADULT; CANCER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR INFECTION; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; FEMALE; FOLLOW UP; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SKIN CARCINOMA;

EID: 0041831304     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00669-9     Document Type: Conference Paper

References (13)

1. Sheil A.G.R., Disney A.P.S., Mathew T.G., et al. Transplant Proc. 25:1993;1383.
2. Penn I. Transplant Proc. 31:1999;1260.
3. Dantal J., Hourmant M., Cantarovich D., et al. Lancet. 351:1998;623.
4. Danpanich E., Kasiske B.L. Transplantation. 68:1999;1859.
5. Ramsay H.M., Fryer A.A., Reece S., et al. Am J Kidney Dis. 36:2000;167.
6. Bray F., Sankila R., Ferlay J., et al. Eur J Cancer. 38:2002;99.
7. London N.J., Farmery S.M., Will E.J., et al. Lancet. 346:1995;403.
8. Hiesse C., Rieu P., Kria F., et al. Transplant Proc. 29:1997;831.
9. Behrend M., Kolditz M., Kliem V., et al. Transplant Proc. 29:1997;834.
10. Webb M.C., Compton F., Andrews P.A., et al. Transplant Proc. 29:1997;828.
11. Frances C. Nephrol Dial Transplant. 13:1997;2768.
12. Vilardell J., Oppenheimer F., Talbot-Wright R., et al. Transplant Proc. 24:1992;1948.
13. Opelz G., Henderson R. Lancet. 342:1993;1514.